Home | NGcGM3/VSSP/Montanide ISA 51 vaccine in metastatic breast cancer. Phase II

The revisions let you track differences between multiple versions of a post.

To edit, publish or delete one of the revisions below, click on its saved date.

Published clinical_trials NGcGM3/VSSP/Montanide ISA 51 vaccine in metastatic breast cancer. Phase II has only one revision
RevisionStatus
Saved 04/07/2017 - 4:07pm by lazaracurrent revision (published)
Equipo de Trabajo del RPCEC | CENCEC - MINSAP
rpcec@cencec.sld.cu
Calle 5ta A Edificio CECMED-CENCEC 2do piso e/ 60 y 62 Miramar, Playa.CP 11300. La Habana, Cuba
Telef: (537) 216-4126 | (537) 216-4212 | (537) 216-4218.
Copyright © 2014-2022 All Rights Reserved.